Aurea Biolabs
Aurea Biolabs, a leading name in the biotechnology sector, is headquartered in the United States and operates across various regions globally. Founded in 2015, the company has rapidly established itself as a key player in the fields of biopharmaceutical development and advanced therapeutic solutions. Aurea Biolabs offers a range of innovative services, including contract research, clinical trial management, and custom assay development, distinguished by their commitment to quality and scientific excellence. The company’s unique approach combines cutting-edge technology with a deep understanding of biological systems, ensuring tailored solutions for clients in the life sciences industry. With a strong market position, Aurea Biolabs has achieved significant milestones, including partnerships with prominent research institutions and successful product launches, solidifying its reputation as a trusted partner in biotechnological advancements.
DitchCarbon Score
How does Aurea Biolabs's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Aurea Biolabs's score of 3 is lower than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Aurea Biolabs's reported carbon emissions
Aurea Biolabs, headquartered in the US, currently does not have available carbon emissions data for recent years. As such, specific figures regarding their emissions in kg CO2e, including Scope 1, 2, or 3 emissions, are not provided. In the absence of concrete emissions data, it is important to note that Aurea Biolabs has not outlined any specific reduction targets or initiatives related to carbon emissions. This lack of publicly available information on their climate commitments suggests that the company may still be in the early stages of developing a comprehensive sustainability strategy. As the industry increasingly prioritises climate action, it will be essential for Aurea Biolabs to establish clear goals and transparent reporting to align with global climate standards and expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Aurea Biolabs is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
